Retrospective evaluation of the diagnosis of complicated urinary tract infections in intensive care patients and therapy with oral fosfomycin or nitrofurantoin.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032886

Enrollment

350

Registered

2023-11-02

Start date

2023-11-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N39.0

Interventions

Group 1: All adult patients in the Anesthesiology Intensive Care Unit in 2012-2023 who received therapy with either oral fosfomycin or oral nitrofurantoin. Exclusion criteria: Minor patients*, patien

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: adult departmental ICU patients between 2012 and 2023 treated either with oral fosfomycin or oral nitrofurantoine

Exclusion criteria

Exclusion criteria: non adult patients or patients previously treated with one of the two aforementioned substances

Design outcomes

Primary

Measure	Time frame
Diagnosis correct?	—

Secondary

Measure	Time frame
Course Fever, leukocyte counts in blood count, procalcitonin, ICU length of stay, mortality	—

Countries

Germany

Contacts

Public ContactJohannes Kalbhenn

Universitätsklinikum Freiburg

johannes.kalbhenn@uniklinik-freiburg.de+49 761 270 23121

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026